Toronto Stock Exchange Symbol: DND

    MISSISSAUGA, ON, April 1 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND)
today announced it will hold its Annual Meeting of Shareholders on Thursday,
April 10, 2008 at 4:30 p.m. ET.WHAT:   ANNUAL MEETING OF SHAREHOLDERS

    WHERE:  TORONTO BOARD OF TRADE
            1 FIRST CANADIAN PLACE
            TORONTO, ONTARIO

    WHEN:   THURSDAY, APRIL 10, 2008 AT 4:30 P.M. ET.The meeting will be webcast live. To access the webcast go to:
    http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2198900
    Please connect at least 15 minutes prior to the start of the meeting to
ensure adequate time for any software download that may be required to join
the webcast.

    About Cipher Pharmaceuticals Inc.

    Cipher Pharmaceuticals is a drug development company focused on
commercializing novel formulations of successful, currently marketed molecules
using advanced drug delivery technologies. Cipher's strategy is to in-license
products that incorporate proven drug delivery technologies and advance them
through the clinical development and regulatory approval stages, after which
the products are out-licensed to international partners. Because Cipher's
products are based on proven technology platforms applied to currently
marketed drugs, they are expected to have lower approval risk, shorter
development timelines and significantly lower development costs. The Company's
lead compound, CIP-FENOFIBRATE, received final approval from the U.S. Food and
Drug Administration and Health Canada in the first quarter of 2006. The
product is being marketed in the United States by ProEthic Pharmaceuticals
under the label Lipofen(TM). In addition, Cipher is developing formulations of
the pain reliever tramadol and the acne treatment isotretinoin.
    Cipher is listed on the Toronto Stock Exchange under the symbol 'DND' and
has approximately 24 million shares outstanding. For more information, please
visit www.cipherpharma.com.